Firm at a glance
Amulet Capital Partners is a platform private equity firm founded in 2015 and based in Walnut Creek, California, per its website [S1]. The firm reported approximately $2.5 billion in assets under management as of March 31, 2026 [S2].
What they buy
Amulet Capital Partners concentrates its investment activity in healthcare, with observed portfolio holdings spanning life sciences outsourcing and provider and payor services [S3]. The firm’s publicly disclosed portfolio includes clinical research organizations, healthcare communications providers, and specialty physician practice platforms [S3]. Recent acquisition activity suggests continued focus on healthcare services businesses that support clinical trials and patient care delivery [S4].
Portfolio
Life Sciences Outsourcing
Amulet Capital Partners holds Assembled Intelligence and OPEN Health in this sector [S3]. The firm’s June 2026 acquisition of Alliance Clinical Network and Atlas Clinical Research also falls within clinical research services [S4].
Provider & Payor Services
The firm’s portfolio in this category includes United Vein & Vascular Centers and U.S. Digestive Health [S3]. In May 2026, Amulet acquired TFP Fertility Group, expanding its presence in specialty physician services [S4].
Recent activity (last 24 months)
* June 2, 2026: Acquisition of Alliance Clinical Network and Atlas Clinical Research [S4]
* May 7, 2026: Acquisition of TFP Fertility Group [S4]
How this firm fits a seller
Amulet Capital Partners appears positioned for healthcare services businesses, particularly those serving the life sciences industry or operating specialty physician practices. The firm’s 2023 fund vintage suggests active deployment capital [S1]. For owner-operators in clinical research services, healthcare communications, or specialty medical practices, the firm’s sector concentration may indicate operational familiarity with healthcare regulatory environments and reimbursement models. The firm’s recent transaction pace, with two acquisitions in spring 2026, indicates ongoing deal activity [S4].
Sources
[S1] https://amuletcapital.com/about/ (as of 2026-03-31)
[S2] https://amuletcapital.com (as of 2026-03-31)
[S3] https://amuletcapital.com/portfolio/ (as of 2026-03-31)
[S4] https://amuletcapital.com/news/ (as of 2026-03-31)
Frequently asked questions
Does Amulet Capital Partners buy Life Sciences Outsourcing businesses?
Yes, Amulet Capital Partners has demonstrated investment activity in life sciences outsourcing, with portfolio companies including Assembled Intelligence and OPEN Health [S3]. The firm’s June 2026 acquisition of Alliance Clinical Network and Atlas Clinical Research further confirms active interest in clinical research and related services [S4].
What companies has Amulet Capital Partners acquired recently?
In the past year, Amulet Capital Partners acquired TFP Fertility Group in May 2026 and Alliance Clinical Network along with Atlas Clinical Research in June 2026 [S4]. These transactions reflect the firm’s continued focus on healthcare services platforms.
Where is Amulet Capital Partners based and how big is the firm?
Amulet Capital Partners maintains offices in Walnut Creek, California [S1]. The firm reported approximately $2.5 billion in assets under management as of March 31, 2026, and is currently investing from a 2023 vintage fund [S1][S2].
Is Amulet Capital Partners still actively acquiring?
Yes, Amulet Capital Partners completed two acquisitions in spring 2026, with transactions closing in May and June [S4]. This recent activity suggests the firm remains active in the market for healthcare services businesses.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.